NCT06993506 2025-05-29Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruiting500 enrolled